Skip to main content

Refactor — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

60
Companies
$1.0B
Total invested
$23.6M
Avg. check
51
Industries
Biotechnology 10Artificial Intelligence (AI) 6Life Science 5Health Care 5Software 3Genetics 3+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 60
BioRender
April 2023

BioRender develops a science visualization platform for the pharmaceutical and life sciences industries.

Graphic Design · Toronto$15.3M Series A
Vital
March 2023

AI-Powered digital experiences for the most vital points in care.

Artificial Intelligence (AI) · Atlanta$24.7M Series B
Melonfrost
January 2023

Melonfrost is a biotechnology company based in Brooklyn, New York.

Artificial Intelligence (AI) · Brooklyn$7.0M Seed
Curative
November 2025

Curative provides employer-based health insurance plans and healthcare services.

Employee Benefits · Austin$150.0M Series B
Gencove
October 2021

Industrial-scale genome sequencing

Biotechnology · New York$10.0M Series A
Pila Energy
October 2025

Pila Energy develops innovative battery systems and software to provide energy security and energy management for homes and businesses.

Energy · San Francisco$4.0M Seed
Nome Bio
October 2025

Nome is the Operating System for Personalized Therapies™ — developing custom treatments for rare disease patients, families, and clinicians.

Artificial Intelligence (AI) · San Diego$2.7M Seed
The Biological Computing
February 2026

The Biological Computing integrates biological neurons with artificial neural networks to develop a living computer.

Artificial Intelligence (AI) · Baltimore$25.0M Seed
Berkeley Yeast
December 2025

Berkeley Yeast bioengineers yeast strains that elevate fermentation for brewers and beyond.

Brewing · OaklandSeries A
Hexium
July 2025

Hexium enriches isotopes for next-gen reactors using LLNL AVLIS including Lithium and Uranium

Energy · Austin$13.0M Undisclosed
Parallel Bio
June 2025

Parallel Bio develops tools that help in the discovery and development of immunotherapies.

Biotechnology · Watertown$21.0M Series A
Remedy Scientific
April 2025

Remedy Scientific is a pioneering environmental remediation technology company that utilizes sensors to assess pollutants accurately.

Artificial Intelligence (AI) · San Francisco$11.0M Seed
Modulo Bio
March 2025

Modulo Bio is a biotech company that offers a platform for reprogramming neurocells to improve immunity.

Biopharma · San Diego$4.8M Seed
General Galactic
March 2025

General Galactic is a space tech startup developing advanced spacecraft and propulsion systems

Aerospace · El SegundoSeed
Causal Labs
March 2025

Causal Labs is a research company building general causal intelligence

Artificial Intelligence (AI) · San Francisco$6.0M Seed
Macro Oceans
September 2024

Macro Oceans develops technology to harness the restorative power of seaweed.

Biotechnology · San Francisco$2.5M Seed
Granza Bio
July 2024

Granza Bio is a company that developing cancer therapies based on human body's immune system.

Biopharma · San Francisco$7.1M Seed
Phytoform Labs
May 2024

Phytoform Labs is a biotechnology company that focuses on resilient and sustainable crops.

Agriculture · Salisbury$1.3M Grant
Bedrock Materials
May 2024

Bedrock Materials is a startup company developing materials and manufacturing procedures for low-cost sodium-ion batteries.

Battery · Palo Alto$9.0M Seed
Rubedo Life Sciences
April 2024

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

Biotechnology · Sunnyvale$40.0M Series A
YourChoice Therapeutics
March 2024

YourChoice Therapeutics is revolutionizing contraceptives for men and women by developing novel non-hormonal contraceptive products.

Health Care · Berkeley$500K Grant
Checkerspot
February 2023

Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.

Biotechnology · Alameda$55.0M Series C
Spora Health
August 2022

Spora Health is a primary care provider designed for people of color.

Fitness · San FranciscoSeries Unknown
FYTO
July 2022

FYTO is a technology company that develops systems for farmers to grow crops using fewer resources.

AgTech · Cambridge$15.0M Series A

Where Refactor invests

Biotechnology10
Artificial Intelligence (AI)6
Life Science5
Health Care5
Software3
Genetics3

About Refactor's portfolio

How many companies has Refactor invested in?

Refactor has invested in 60 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Refactor invest in?

Refactor's top investment sectors include Biotechnology, Artificial Intelligence (AI), Life Science, Health Care, Software. The firm invests across 51 different industry categories.

What is Refactor's largest investment?

Among tracked funding rounds, Curative received $150.0M in a Series B round. Refactor's total known invested capital is $1.0B.

What is the average investment size for Refactor?

Refactor's average investment size is $23.6M across its portfolio of 60 companies.

What are Refactor's most recent investments?

Recent Refactor portfolio additions include BioRender, Vital, Melonfrost, Curative, Gencove. These companies were founded in 2020 or later.

Reach the founders behind these 60 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →